Lithotripsy Devices Market to Reach $3.8 Billion by 2035

Lithotripsy devices market was valued at $1.9 billion in 2025 and is projected to reach $3.8 billion by 2035, growing at a CAGR of 7.3% during the forecast period (2026-2035). The rising global burden of urinary stone disease, particularly kidney and ureteral stones, which is directly increasing procedural demand for stone fragmentation systems across hospitals, specialty urology centers, and ambulatory surgical settings. According to the U.S National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), kidney stones affect about 11% of men and 6% of women in the United States at least once during their lifetime, highlighting a large recurring treatment population requiring interventional care. In parallel, recent NHANES-based findings published through the U.S. National Library of Medicine reported that kidney stone prevalence in U.S. adults reached 11.0%, while annual incidence was 2,054 cases per 100,000 adults, confirming sustained patient inflow into the treatment pathway.

Browse the full report description of “Lithotripsy Devices Market Size, Share & Trends Analysis Report by Product Type (Extracorporeal Lithotripsy Devices and Intracorporeal Lithotripsy Devices), by Application (Kidney Stones, Ureteral Stones, Bladder Stones, Pancreatic Stones, and Bile Duct Stones), by End User (Hospitals, Specialty Urology Clinics, and Ambulatory Surgical Centers (ASCs)), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/lithotripsy-devices-market

This growing disease burden is highly relevant for market estimation because a meaningful share of symptomatic and recurrent stone patients progress from conservative management to procedural treatment using extracorporeal shock wave lithotripsy and intracorporeal laser lithotripsy systems. Rising obesity, diabetes, dehydration risk, aging demographics, and dietary factors are further expanding the eligible patient base, particularly in developed and urbanizing markets. As procedure volumes increase, healthcare providers continue investing in advanced lithotripsy capital equipment, replacement systems, disposable fibers, probes, and service contracts. This creates a recurring revenue cycle across both installed base upgrades and consumables, making disease prevalence and recurrence rates one of the most reliable leading indicators for long-term revenue forecasting in the global lithotripsy devices market.

Innovation Leaders Transforming the Lithotripsy Devices Market

The key players in the lithotripsy devices market include Boston Scientific Corporation, Dornier MedTech GmbH, Olympus Corporation, Richard Wolf GmbH, Karl Storz SE & Co. KG, among others. These companies are advancing innovation in lithotripsy devices through the development of high-precision stone fragmentation systems, improved laser and shock wave technologies, and minimally invasive treatment platforms, enabling faster and safer removal of urinary and biliary stones across modern healthcare facilities while supporting growing demand for efficient, outpatient, and patient-centric urological care solutions.

• In January 2026, Boston Scientific begun a limited market release of its Seismiq Peripheral IVL System following the first completed peripheral procedures with the device. The next-generation intravascular lithotripsy (IVL) platform is designed to treat complex calcified vascular disease with improved deliverability, visibility, precise control, and consistent acoustic performance in challenging anatomies.

• In January 2026, Boston Scientific reported the first peripheral procedures using its Seismiq IVL System as part of a limited US rollout. The laser-based intravascular lithotripsy (IVL) technology, acquired through the company’s purchase of Bolt Medical, is designed to treat complex calcified peripheral and coronary artery disease by generating acoustic pressure waves inside a balloon catheter to fracture calcium.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Application
  • By End User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Boston Scientific Corporation, Dornier MedTech GmbH, Olympus Corporation, Richard Wolf GmbH, Karl Storz SE & Co. KG, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Lithotripsy Devices Market Report Segment

By Product Type

• Extracorporeal Lithotripsy Devices
• Intracorporeal Lithotripsy Devices

By Application

• Kidney Stones
• Ureteral Stones
• Bladder Stones
• Pancreatic Stones
• Bile Duct Stones

By End User

• Hospitals
• Specialty Urology Clinics
• Ambulatory Surgical Centers (ASCs)

Global Lithotripsy Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/lithotripsy-devices-market